BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36704231)

  • 1. 3D printing of pharmaceuticals for disease treatment.
    Chakka LRJ; Chede S
    Front Med Technol; 2022; 4():1040052. PubMed ID: 36704231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
    Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
    Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
    Funk NL; Fantaus S; Beck RCR
    Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications.
    Karalia D; Siamidi A; Karalis V; Vlachou M
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional printed dosage forms based on disease-focussed perspectives.
    Gültekin HE; Tuğcu Demiröz F; Tort S; Acartürk F
    J Pharm Pharmacol; 2022 Oct; 74(10):1406-1426. PubMed ID: 36215694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
    Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
    Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereolithography 3D printing technology in pharmaceuticals: a review.
    Deshmane S; Kendre P; Mahajan H; Jain S
    Drug Dev Ind Pharm; 2021 Sep; 47(9):1362-1372. PubMed ID: 34663145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.
    Azad MA; Olawuni D; Kimbell G; Badruddoza AZM; Hossain MS; Sultana T
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new chapter in pharmaceutical manufacturing: 3D-printed drug products.
    Norman J; Madurawe RD; Moore CM; Khan MA; Khairuzzaman A
    Adv Drug Deliv Rev; 2017 Jan; 108():39-50. PubMed ID: 27001902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Printing Technology in Drug Delivery: Recent Progress and Application.
    Kotta S; Nair A; Alsabeelah N
    Curr Pharm Des; 2018; 24(42):5039-5048. PubMed ID: 30520368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated review on application of 3D printing in fabricating pharmaceutical dosage forms.
    Parhi R; Jena GK
    Drug Deliv Transl Res; 2022 Oct; 12(10):2428-2462. PubMed ID: 34613595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of feed forces to improve process understanding of Fused Deposition Modeling 3D printing and to ensure mass conformity of printed solid oral dosage forms.
    Gottschalk N; Quodbach J; Elia AG; Hess F; Bogdahn M
    Int J Pharm; 2022 Feb; 614():121416. PubMed ID: 34958898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
    Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
    AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.